LSBio
Human IL22 Protein (Recombinant)

Activity was determined by the ability to inhibit growth of human A549 cancer cells at concentrations ranging between 50-100 ng/mL.

Human IL22 Protein (Recombinant)

Expression SystemEscherichia coli (Prokaryotic)
Format:Lyophilized
See all IL22 Proteins & Peptides →
$297.00each
Catalog Number: LS-G131303-10

For bulk orders or custom formulations:

Request a Quote

Overview

Description
IL22 Protein LS-G131303 is a Recombinant Human IL22 produced in E. coli. It is biologically active and is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Category
Proteins & Peptides > Proteins > Recombinant Proteins
Alternative Names
Cytokine Zcyto18 | ILTIF | Interleukin 22 | IL-22 | IL-D110 | TIFIL-23 | Zcyto18 | IL-TIF | IL22 | Interleukin-22
Origin Species
Hu
NCBI GenBank
NM_020525
SwissProt
Q9GZX6

Protein

Expression System
E.coli
Molecular Weight
~17 kDa
Protein Type
Recombinant

Format

Purity
>95%
Conjugate/Label
Unconj
Endotoxin Level
< 1.0 EU/µg
Format
Lyophilized
Formulation
Lyophilized from Sterile Solution 20 mM Tris, pH 8.0, 500 mM NaCl
Purity Measurement Method
SDS-PAGE

Storage & Handling

Storage Conditions
Reconstitute and aliquot for up to 6 months at -20°C, or up to 1 month at 2°C to 8°C, with a carrier protein. Avoid freeze-thaw cycles.

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.